For example, inhibition of sodium nitroprusside-mediated NO release and increased production of transcripts coding for antioxidant enzymes (i.e., SOD1, GPx1 and CAT) have been reported upon melatonin treatment in neuroblastoma cells and HUVEC, respectively [451,453]. The gene discussed is GPX1; the disease is neuroblastoma.